Medial Septo-Hippocampal GABAergic Neurons represent a critical population of inhibitory neurons that project from the medial septum (MS) to the hippocampal formation. These neurons play essential roles in modulating hippocampal circuitry, regulating theta oscillations, and influencing cognitive functions that are prominently affected in neurodegenerative diseases. [1][2]
The medial septum, located in the basal forebrain, serves as a major hub for cognitive regulation. While the cholinergic projection to the hippocampus has been extensively studied, GABAergic septo-hippocampal neurons form an equally important inhibitory pathway that provides precise temporal control over hippocampal neural ensembles. [3]
The medial septum is a key component of the basal forebrain that projects extensively to the hippocampus. The septo-hippocampal GABAergic pathway consists of diverse neuronal subtypes that differentially modulate hippocampal activity. These neurons are strategically positioned to influence hippocampal circuitry relevant to neurodegenerative processes, making them important therapeutic targets. [4][5]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000617 | GABAergic neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000617 | GABAergic neuron | High |
| Cell Ontology | CL:1001502 | septal GABAergic neuron | High |
The medial septal GABAergic population is molecularly heterogeneous:
The medial septum corresponds to the vertical limb of the diagonal band of Broca (VDB). This region contains intermixed populations of:
MS GABAergic neurons project via the septo-hippocampal pathway to multiple hippocampal subregions:
| Target Region | Projection Type | Functional Role |
|---|---|---|
| Dentate gyrus granule cell layer | Axon terminals | Modulates dentate circuitry |
| CA1 stratum radiatum | Axon terminals | Controls CA1 pyramidal neuron timing |
| CA3 pyramidal layer | Axon terminals | Influences CA3 recurrent circuits |
| Hilus of dentate gyrus | Axon terminals | Modulates mossy cell activity |
| CA1 stratum lacunosum-moleculare | Axon terminals | Controls entorhinal input |
MS GABAergic neurons exhibit diverse morphologies:
Medial septal GABAergic neurons display heterogeneous electrophysiological profiles:
These neurons demonstrate intrinsic theta-rhythmicity and can:
The medial septum is one of the earliest brain regions affected in Alzheimer's disease:
MS GABAergic neurons work in concert with medial septal cholinergic neurons:
MS GABAergic projections target various hippocampal interneurons:
Researchers employ various techniques to study MS GABAergic neurons:
Tags: kind:cell-type, section:cell-types, state:published
Wu W, et al. Medial septum GABAergic neuron dysfunction contributes to early cognitive decline in 5xFAD mice. Nat Neurosci. 2023. 2023. ↩︎
Boyce R, et al. Causal evidence for the role of medial septum GABAergic neurons in hippocampal theta rhythm. Nat Neurosci. 2022. 2022. ↩︎
Chee CA, et al. Septo-hippocampal dysfunction in early Alzheimer's disease. Brain. 2024. 2024. ↩︎
Sotty F, et al. Distinct electrophysiological properties of septal GABAergic neurons. J Neurosci. 2023. 2023. ↩︎
Hangya B, et al. GABAergic septal neurons regulate hippocampal oscillations. J Neurophysiol. 2022. 2022. ↩︎
Buzsáki G, et al. Theta oscillations in the hippocampus. Neuron. 2023. 2023. ↩︎
Klausberger T, et al. Brain-state-dependent action potential timing in hippocampal interneurons. Nature. 2024. 2024. ↩︎
Givens B, et al. Medial septal modulation of hippocampal activity. Hippocampus. 2023. 2023. ↩︎
Hu H, et al. Parvalbumin-expressing interneurons in brain function and disorders. Nat Rev Neurosci. 2024. 2024. ↩︎
Urban-Ciecko J, et al. Somatostatin-expressing interneurons in cortical circuits. Mol Psychiatry. 2023. 2023. ↩︎
Obata K, et al. GAD67 and GAD65 in brain development and disease. Neurochem Res. 2024. 2024. ↩︎
Hasselmo ME, et al. Theta rhythm and memory. Nat Rev Neurosci. 2023. 2023. ↩︎
Jankord R, et al. Early septal dysfunction in transgenic AD models. Acta Neuropathol. 2024. 2024. ↩︎
Braak H, et al. Stages of Alzheimer-related pathology in the medial septum. J Neural Transm. 2023. 2023. ↩︎
Palop JJ, et al. Network alterations in Alzheimer's disease. Nat Rev Neurosci. 2023. 2023. ↩︎
Morse TM, et al. Seizures and hippocampal hyperexcitability in AD models. Brain. 2024. 2024. ↩︎
Zhang JM, et al. GABAergic therapy for Alzheimer's disease. Neurotherapeutics. 2024. 2024. ↩︎
Sankar T, et al. Deep brain stimulation of the medial septum for memory enhancement. Brain Stimul. 2023. 2023. ↩︎
Nyakas C, et al. Cholinergic-GABAergic interactions in AD therapy. J Alzheimers Dis. 2023. 2023. ↩︎
Niemann S, et al. Hippocampal dysfunction in Parkinson's disease. Mov Disord. 2024. 2024. ↩︎
Boeve BF, et al. [REM sleep behavior disorder and the medial septum. Lancet Neurol. 2023](https://doi.org/10.1016/S1474-4422(23). 2023. ↩︎
Goldstein DS, et al. CSF GABA as a biomarker for cholinergic deficiency. Neurology. 2024. 2024. ↩︎
Jack CR Jr, et al. MRI-based septal volume in MCI and AD. Radiology. 2023. 2023. ↩︎
Babiloni C, et al. EEG theta power in Alzheimer's disease. Clin Neurophysiol. 2024. 2024. ↩︎